MedTrace Logo

Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions

NCT00595647 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 162

Last updated 2015-04-21

No results posted yet for this study

Summary

Prospective multicenter controlled randomized trial to compare the safety and efficacy of drug eluting vs. bare metal stents in percutaneous coronary interventions of saphenous vein grafts. Hypothesis: Survival and outcome will be significantly better in patients receiving DES than in patients receiving BMS regarding both short-term and long-term outcome.

Conditions

Interventions

DEVICE

Drug eluting stent

Implantation of stent

DEVICE

Bare metal stent

Implantation of stent

Sponsors & Collaborators

  • University of Leipzig

    collaborator OTHER

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Matthias Pfisterer, MD · University Hospital, Basel, Switzerland

  • Raban Jeger, MD · University Hospital, Basel, Switzerland

  • Sven Möbius-Winkler, MD · University of Leipzig/Heart Center, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • Denmark
  • Germany
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00595647 on ClinicalTrials.gov